Kenvue

Kenvue, the world’s largest pure-play consumer health company by revenue, was officially established on February 23, 2022, as part of a strategic separation from Johnson & Johnson. With a legacy rooted in over 135 years of commitment to consumer health, Kenvue operates with a clear mission: to improve everyday care for consumers around the globe. The company manages a vast portfolio of well-known brands, including Tylenol, Neutrogena, Aveeno, and Band-Aid, that cater to various health and wellness needs. These brands are synonymous with quality and are trusted by healthcare professionals and consumers alike.

At Kenvue, innovation is driven by the integration of science and consumer insights. The leadership, spearheaded by CEO Thibaut Mongon, emphasizes the importance of understanding consumer behaviors and preferences to enhance product development and marketing strategies. Kenvue is not just about selling products; it's about fostering trust and empowering consumers to make informed health choices. With operations based in Skillman, New Jersey, Kenvue is committed to environmental sustainability and community engagement, aiming to make a positive impact beyond just health care. As they continue on this journey, Kenvue focuses on expanding access to its products, thereby ensuring that more than a billion lives are touched by its solutions for everyday care.